IQ Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Imperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
Imperagen is a techbio startup developing a closed-loop enzyme engineering platform for pharmaceutical manufacturing, personal care and sustainable chemical production. The platform combines quantum physics simulations, AI modelling and laboratory automation to improve enzyme performance faster than traditional screening methods.
Nyobolt raises £44m in funding led by Symbotic to build ultra-fast charging batteries for autonomous machines and data centres
Nyobolt develops high-power, fast-charging battery systems designed to deliver continuous energy for robotics, automation and data centre infrastructure. Its technology enables machines and systems to operate without downtime in environments where conventional batteries cannot meet performance demands.
Rivan raises £25m in funding led by IQ Capital to produce synthetic natural gas using renewable energy
Rivan is a synthetic fuel company that produces carbon-neutral natural gas using renewable energy and captured CO2. It develops and manufactures systems that enable domestic fuel production for industries reliant on gas infrastructure.
Tropic secures £80m Series C led by Forbion and Corteva for gene-edited tropical crop varieties
Tropic develops gene-edited tropical crop varieties designed to improve disease resistance, shelf life and agricultural productivity. Its products aim to help growers, exporters and food supply chains manage crop disease, reduce waste and increase yields.
Isembard unlocks £37m Series A led by Union Square Ventures to manufacture high-precision components for critical industries
Isembard manufactures high-precision components for aerospace, defence, energy and robotics companies. It operates its own and franchisee factories using proprietary software that integrates quoting, scheduling, supply chain, manufacturing, quality control and delivery.
Trogenix raises £70m Series A led by IQ Capital to advance precision cancer therapies into clinical trials
Trogenix develops precision genetic medicines for aggressive solid tumours, using targeted delivery systems designed to kill cancer cells and stimulate immune responses while limiting damage to healthy tissue.
Synthesized raises £15m Series A led by Redalpine to automate the most difficult parts of testing with agentic AI
Synthesized provides agentic AI infrastructure for software testing, automating the creation of realistic, compliant test data and environments so regulated organisations can test and release software faster and more safely.
DaltonTx launches with £4m seed round from Redalpine, IQ Capital and Seedcamp to build the intelligence backbone of drug discovery
DaltonTx builds an adaptive AI platform for drug discovery that integrates directly into scientific workflows, helping research teams analyse data, design molecules and make decisions across small molecule and biologic programmes.
Neurovalens secures £6m in funding led by Investment Fund for Northern Ireland to expand non-invasive neuro-technology
Neurovalens designs non-invasive neurostimulation devices that treat conditions such as insomnia and anxiety, using wearable technology cleared for clinical use.
Nyobolt raises £23m in funding led by IQ Capital as it scales ultra-fast charging systems for vehicles
Nyobolt develops ultra-fast charging battery technology for vehicles and power-intensive applications, enabling high-power recharge cycles with minimal degradation to reduce downtime in automotive, industrial and data centre environments.
Mindgard raises £6.4m led by .406 Ventures to safeguard AI with industry-first AI security solution
Mindgard builds security testing tools specifically for AI systems, identifying runtime vulnerabilities such as prompt injection and jailbreaks that traditional software security cannot detect.
IQ Capital and Plural lead £3.6m funding for Molyon to develop next-gen lithium-sulfur batteries with double the energy density
Molyon develops lithium-sulfur batteries with higher energy density than lithium-ion, targeting lighter, longer-range power solutions for applications such as drones, robotics and advanced mobility.
BMLL secures £16m strategic investment led by Optiver to supercharge growth
BMLL supplies high-granularity historical market data and analytics, enabling banks, asset managers and exchanges to analyse how equities, futures and options markets behave at microsecond and nanosecond levels.
More venture news
- 21 May 2026
ImperagenImperagen secures a £5m seed round led by PXN Ventures to accelerate the process of enzyme engineering
SeedLife Sciences - 11 May 2026
Scarlet TherapeuticsScarlet Therapeutics raises a £3.2m seed round led by Eos Advisory to advance red blood cell treatments for diseases
SeedLife Sciences - 12 May 2026
White CircleWhite Circle raises £8m from leading industry angels for platform that monitors AI model behaviour
SeedAI
